Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts
Open accessAbstract
Cryptococcus gattii recently emerged as the causative agent of cryptococcosis in healthy individuals in western North America, despite previous characterization of the fungus as a pathogen in tropical or subtropical regions. As a foundation to study the genetics of virulence in this pathogen, we sequenced the genomes of a strain (WM276) representing the predominant global molecular type (VGI) and a clinical strain (R265) of the major genotype (VGIIa) causing disease in North America. We compared these C. gattii genomes with each other and with the genomes of representative strains of the two varieties of Cryptococcus neoformans that generally cause disease in immunocompromised people. Our comparisons included chromosome alignments, analysis of gene content and gene family evolution, and comparative genome hybridization (CGH). These studies revealed that the genomes of the two representative C. gattii strains (genotypes VGI and VGIIa) are colinear for the majority of chromosomes, with some minor rearrangements. However, multiortholog phylogenetic analysis and an evaluation of gene/sequence conservation support the existence of speciation within the C. gattii complex. More extensive chromosome rearrangements were observed upon comparison of the C. gattii and the C. neoformans genomes. Finally, CGH revealed considerable variation in clinical and environmental isolates as well as changes in chromosome copy numbers in C. gattii isolates displaying fluconazole heteroresistance. IMPORTANCE Isolates of Cryptococcus gattii are currently causing an outbreak of cryptococcosis in western North America, and most of the cases occurred in the absence of coinfection with HIV. This pattern is therefore in stark contrast to the current global burden of one million annual cases of cryptococcosis, caused by the related species Cryptococcus neoformans , in the HIV/AIDS population. The genome sequences of two outbreak-associated major genotypes of C. gattii reported here provide insights into genome variation within and between cryptococcal species. These sequences also provide a resource to further evaluate the epidemiology of cryptococcal disease and to evaluate the role of pathogen genes in the differential interactions of C. gattii and C. neoformans with immunocompromised and immunocompetent hosts.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The main mechanisms related to C. gattii heteroresistance are copy number increase in chr10, chr9 and chr11 for the VGI genotype and copy number increase in chr3 for the VGII genotype.
“The main mechanisms that could be related to C. gattii heteroresistance are copy number increase in chr10, chr9 and chr11 for the VGI genotype and copy number increase in chr3 for the VGII genotype [138].”
From Insight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance (2025) · cites this paper as [138]
The Results and Discussion section (page not specified) reports elevated copies of chromosomes 9, 10 and 11 in one heteroresistant VGI strain, and chromosome 3 in one VGII strain. It also reports different chromosome changes in the other strains, so it does not establish these as the main mechanisms for each genotype. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 100 · Cited by 202
- Authors
- D’Souza, C. A., Kronstad, J. W., Taylor, G., Warren, R., Yuen, M., Hu, G., Jung, W. H., Sham, A., Kidd, S. E., Tangen, K., Lee, N., Zeilmaker, T., Sawkins, J., McVicker, G., Shah, S., Gnerre, S., Griggs, A., Zeng, Q., Bartlett, K., Li, W., Wang, X., Heitman, J., Stajich, J. E., Fraser, J. A., Meyer, W., Carter, D., Schein, J., Krzywinski, M., Kwon-Chung, K. J., Varma, A., Wang, J., Brunham, R., Fyfe, M., Ouellette, B. F. F., Siddiqui, A., Marra, M., Jones, S., Holt, R., Birren, B. W., Galagan, J. E., & Cuomo, C. A.
- Affiliations
- University of British Columbia (CA)
- BC Cancer Agency (CA)
- Chung-Ang University (KR)
- The University of Sydney (AU)
- Broad Institute (US)
- Duke Medical Center (US)
- University of California, Riverside (US)
- The University of Queensland (AU)
- National Institutes of Health (US)
- BC Centre for Disease Control (CA)
- Island Health (CA)
- Ontario Institute for Cancer Research (CA)
- ORCID
- Kronstad, J. W.
- Warren, R.
- Yuen, M.
- Hu, G.
- Jung, W. H.
- Sham, A.
- Kidd, S. E.
- McVicker, G.
- Shah, S.
- Griggs, A.
- Zeng, Q.
- Bartlett, K.
- Li, W.
- Heitman, J.
- Stajich, J. E.
- Fraser, J. A.
- Meyer, W.
- Carter, D.
- Krzywinski, M.
- Kwon-Chung, K. J.
- Wang, J.
- Brunham, R.
- Ouellette, B. F. F.
- Siddiqui, A.
- Marra, M.
- Jones, S.
- Holt, R.
- Birren, B. W.
- Galagan, J. E.
- Cuomo, C. A.
- Venue
- mBio
- Publisher
- American Society for Microbiology
- Published
- 2011-03
- Volume
- 2
- Issue
- 1
- Pages
- e00342-10
- ISSN
- 2150-7511 (ISSN-L)
- 2161-2129
- PMC
- PMC3037005
- OpenAlex
- W1993548583
- Cited by
- 202
- References
- 100
- Citations by year
- 2026: 2 · 2025: 12 · 2024: 8 · 2023: 11 · 2022: 11 · 2021: 15 · 2020: 12 · 2019: 12 · 2018: 15 · 2017: 19 · 2016: 11 · 2015: 12 · 2014: 17 · 2013: 16 · 2012: 18
- FWCI
- 14.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- mBio (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc-sa)
- Funders
- Howard Hughes Medical Institute (55000640)
- Genome Canada
- Broad Institute (U54HG003067)
- Genome British Columbia
- British Columbia Centre for Disease Control
- National Institutes of Health (2r01ai050113-16a1, R01‐grant, AI50113, AI053721)
- Canadian Institutes of Health Research
- Medical Research Council
- National Health and Medical Research Council
- National Human Genome Research Institute (U54HG003067)
- National Institute of Allergy and Infectious Diseases (R37AI039115, AI053721, R01 AI50113, R01AI053721, AI50113, R01-AI050113)
- Topics
- Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Plant Pathogens and Fungal Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Yeasts and Rust Fungi Studies
- Keywords
- Cryptococcus gattii, cryptococcosis, emerging fungal pathogens, immunocompetent patient, Cryptococcus neoformans, genomic variation, chromosomal rearrangements, speciation, gene family evolution, copy number variation, clinical and environmental isolates
- MeSH terms
- Animals, Antifungal Agents, Cryptococcosis, Disease Outbreaks, Female, Genotype, Humans, Mice, Inbred C57BL, Molecular Sequence Data, North America, Phylogeny, Genetic Variation, Genome, Bacterial, Evolution, Molecular, Mice, Host-Pathogen Interactions, Cryptococcus gattii
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review